DEXCOM INC
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 5. Other Information
Trading Plans
During the three months ended March 31, 2025, the following Section 16 officers and directors adopted, modified, orterminated a “Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K of the Exchange Act) intended to satisfy the affirmative defense of Rule 10b5-1(c):
| Name | Title | Action | Action Date | Aggregate Number of Shares to be Sold | Expiration Date(1) |
|---|---|---|---|---|---|
| Nicholas Augustinos | Director | Adoption | 3/14/2025 | 9,333 | 3/15/2026 |
| Michael J. Brown | Executive Vice President, Chief Legal Officer | Adoption | 2/21/2025 | 31,125 | 2/20/2026 |
| Mark G. Foletta | Director | Adoption(2) | 3/13/2025 | 8,250 | 3/15/2026 |
| Jacob S. Leach | Executive Vice President, Chief Operating Officer | Adoption | 3/12/2025 | 102,732 | 3/12/2026 |
| Sadie M. Stern | Executive Vice President, Chief Human Resources Officer | Adoption | 2/20/2025 | 22,309 | 5/22/2026 |
| (1) Each trading arrangement permitted or permits transactions through and including the date listed in the table. | |||||
| (2) Adopted on behalf of a trust for which Mr. Foletta serves as a trustee. | |||||
Each of the Rule 10b5-1 trading arrangements disclosed in the above table was made in accordance with our insider trading policy. Transactions made pursuant to such trading arrangements will be disclosed publicly in Section 16 filings with the SEC in accordance with applicable securities laws, rules and regulations.
During the three months ended March 31, 2025, none of our Section 16 officers or directors adopted, modified, orterminated a “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K of the Exchange Act).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.